Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

TRAFALGAR INTERNATIONAL, INC. (TRFA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

TRAFALGAR INTERNATIONAL, INC. (TRFA), most recent 12 months reported: net income $879.66K. Latest balance sheet on file: liquid cash $111. From SEC filings. Others in Pharmaceutical Preparations: Telomir Pharmaceuticals, Inc. · TENAX THERAPEUTICS, INC. · Theriva Biologics, Inc. · Tempest Therapeutics, Inc. · Trevi Therapeutics, Inc. · Turn Therapeutics Inc. · TVARDI THERAPEUTICS, INC. · Tyra Biosciences, Inc.

Stock screener

Watchlist